8-Bromo Cyclic Adenosine Monophosphate
"8-Bromo Cyclic Adenosine Monophosphate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A long-acting derivative of cyclic AMP. It is an activator of cyclic AMP-dependent protein kinase, but resistant to degradation by cyclic AMP phosphodiesterase.
Descriptor ID |
D015124
|
MeSH Number(s) |
D03.633.100.759.646.138.395.225 D13.695.462.200.225 D13.695.667.138.395.225 D13.695.827.068.395.225
|
Concept/Terms |
8-Bromo Cyclic Adenosine Monophosphate- 8-Bromo Cyclic Adenosine Monophosphate
- 8 Bromo Cyclic Adenosine Monophosphate
- Br Cycl AMP
- AMP, Br Cycl
- 8-Bromo-cAMP
- 8 Bromo cAMP
- 8-Bromoadenosine 3',5'-Cyclic Monophosphate
- 8 Bromoadenosine 3',5' Cyclic Monophosphate
- 8-Br Cyclic AMP
- 8 Br Cyclic AMP
- Cyclic AMP, 8-Br
- 8-Bromo Cyclic AMP
- 8 Bromo Cyclic AMP
- Cyclic AMP, 8-Bromo
|
Below are MeSH descriptors whose meaning is more general than "8-Bromo Cyclic Adenosine Monophosphate".
Below are MeSH descriptors whose meaning is more specific than "8-Bromo Cyclic Adenosine Monophosphate".
This graph shows the total number of publications written about "8-Bromo Cyclic Adenosine Monophosphate" by people in this website by year, and whether "8-Bromo Cyclic Adenosine Monophosphate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
1997 | 1 | 1 | 2 |
1998 | 1 | 0 | 1 |
2000 | 1 | 0 | 1 |
2002 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "8-Bromo Cyclic Adenosine Monophosphate" by people in Profiles.
-
Intracellular succinylation of 8-chloroadenosine and its effect on fumarate levels. J Biol Chem. 2010 Mar 12; 285(11):8022-30.
-
Defective coupling of apical PTH receptors to phospholipase C prevents internalization of the Na+-phosphate cotransporter NaPi-IIa in Nherf1-deficient mice. Am J Physiol Cell Physiol. 2007 Feb; 292(2):C927-34.
-
cAMP-mediated mechanisms for pain sensitization during opioid withdrawal. J Neurosci. 2005 Apr 13; 25(15):3824-32.
-
Kappa-opioid receptor-mediated enhancement of the hyperpolarization-activated current (I(h)) through mobilization of intracellular calcium in rat nucleus raphe magnus. J Physiol. 2003 May 01; 548(Pt 3):765-75.
-
PKA modulation of Kv4.2-encoded A-type potassium channels requires formation of a supramolecular complex. J Neurosci. 2002 Dec 01; 22(23):10123-33.
-
The role of apolipoprotein A-I helix 10 in apolipoprotein-mediated cholesterol efflux via the ATP-binding cassette transporter ABCA1. J Biol Chem. 2002 Oct 18; 277(42):39477-84.
-
Ezrin binding domain-deficient NHERF attenuates cAMP-mediated inhibition of Na(+)/H(+) exchange in OK cells. Am J Physiol Renal Physiol. 2001 Aug; 281(2):F374-80.
-
8-chloro-cAMP and 8-chloro-adenosine act by the same mechanism in multiple myeloma cells. Cancer Res. 2001 Jul 15; 61(14):5474-9.
-
8-Bromo-cyclic AMP induces phosphorylation of two sites in SRC-1 that facilitate ligand-independent activation of the chicken progesterone receptor and are critical for functional cooperation between SRC-1 and CREB binding protein. Mol Cell Biol. 2000 Dec; 20(23):8720-30.
-
Phosphorylation of SOX9 by cyclic AMP-dependent protein kinase A enhances SOX9's ability to transactivate a Col2a1 chondrocyte-specific enhancer. Mol Cell Biol. 2000 Jun; 20(11):4149-58.